A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis
Work
Year: 2019
Type: article
Source: Dalton Transactions
Institution Nanjing University
Cites: 33
Cited by: 25
Related to: 10
FWCI: 1.766
Citation percentile (by year/subfield): 87.85
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: closed
Funders National Natural Science Foundation of China, National Natural Science Foundation of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, National Key Research and Development Program of China
Grant IDS 21731004, 31570809, 21877059, BK20150054, 2015CB856300